Neurocrine Biosciences, Inc. (NBIX) by event type

NBIX moves most on price-target raises — a median of -0.12% at 30 minutes across 104 measured events. Each row is measured over the last three years and read against the price at its own news timestamp. Back to the NBIX overview →

By event type

How NBIX reacts across 6 measured event types.

EventEventsMedian 30-min% positiveMedian to close
Analyst upgrades
1,528 of 2,717
32-0.03%50%-0.30%
Analyst downgrades
1,104 of 2,603
20+0.06%60%-0.14%
Coverage initiations
950 of 2,283
32+0.07%59%+0.63%
Rating reiterations
1,207 of 3,522
214+0.04%53%-0.36%
Price-target raises
1,391 of 1,790
104-0.12%43%-0.45%
Price-target cuts
1,054 of 1,527
34-0.10%41%-0.29%

Last 3 years, pulled 2026-09-21. Reaction = percent move vs. the price at the news timestamp. Counts and medians only. The rank under each event type orders every name measured for it by median 30-min reaction, most positive first — so a low rank on a downgrade means this name falls harder than most, not that it moves less. Names with an identical median share a rank; a name the cross-section does not carry shows no rank rather than a guessed one.

That’s how NBIX usually reacts — get an email when it moves on news →
Keep exploring

Every name measured for these event types: Analyst upgrades → · Analyst downgrades → · Coverage initiations → · Rating reiterations → · Price-target raises → · Price-target cuts → · NBIX overview →

Other Healthcare names, measured the same way

TickerEventsMedian 30-min% positive
Kadmon Holdings, Inc. (KDMN)6280.00%46%
GTX (GTXI)6230.00%45%
Viveve Medical, Inc. (VIVE)621-0.82%38%
CHINA BIOLOGIC PRODUCTS (CBPO)619-0.04%42%

Same sector, same measurement: percent move vs. the price at the news timestamp, read at 30 minutes. Sample sizes differ, so the medians are comparable but the confidence behind them is not.